Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled cross-over trial of APL510 (melatonin) for insomnia in elderly subjects
2004-003939-32Phase 3Completed
- Sponsor
- Alliance Pharma
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in Insomnia, sponsored by Alliance Pharma. Primary endpoint: Total sleep time. Started Jul 2005; status: completed.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2004-003939-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003939-32.